Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
Introduction: EUS-guided radiofrequency ablation (EUS-RFA) is emerging as safe and effective treatment for pancreatic neoplasms.
Conference:
Presenting Author:
Authors: Crinò S, Napoleon B, Lakhtakia S, Borbath I, Caillol F,
Keywords: Endoscopy, enucleation, hypoglycaemia,
#2925 A Single Centre Experience of Open Surgery for Pancreatic Insulinomas on 88 Patients
Introduction: Insulinomas are functioning pancreatic neuroendocrine neoplasms (NENs), typically small and with a benign clinical course in more than 90% of cases.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Milanetto A, Da Broi M, Liço V, De Carlo E, Pedrazzoli S,
Keywords: pancreas, insulinoma, surgery,
Introduction: Case: A 58-year-old man representing cold sweat, palpitation and nausea was admitted to our hospital and was pointed out parathyroid, pancreatic and superior mediastinal masses with CT.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Nakano K, Masui T, Sato A, Ito T, Anazawa T,
Keywords: insulinoma, SACI test, MEN1,
Introduction: Insulinoma is the most common endocrine pancreatic tumor. It is mostly benign and single.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Pasquali C
Authors: Moletta L, Milanetto A, Lico V, Alaggio R, Sperti C,
Keywords: organic hyperinsulinism, neuroendocrine pancreatic tumors, pancreatic insulinoma,
#479 Efficacy and Safety of Everolimus in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Introduction: Everolimus is a treatment option for patients with pancreatic NETs, while its use in patients with gastrointestinal NETs still remains to be defined.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Ambrosio M, Guerra A, Lupo S, Bondanelli M, Sartori S,
Keywords: Everolimus, GEP-NET, efficacy, side effects,
Our website automatically sets cookies, which are technically necessary for the operation of the website. By clicking "OK", Google Analytics and the associated cookies are also activated for the purpose of website analysis and optimization. Detailed Information and the possibility to revoke your consent at any time, you can find in our privacy policy.
These cookies are so-called "session cookies." They are automatically deleted after your visit.
Protects you from Cross-Site-Request-Forgery attacks.
Saves the current PHP session.
For webinar purposes, ENETS uses VIMEO as an embedded iframe on MY ENETS. VIMEO implements its own tracking system, which is beyond the of ENETS responsibility. By watching ENETS videos on the ENETS website, you also agree to the conditions of VIMEO: https://vimeo.com/privacy
This website uses Google Analytics, a web analytics service. It is operated by Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. Google Analytics cookies are stored based on your consent Art. 6 (1) (a) DSGVO/GDPR, which we confirm via the consent banner.
For more information about how Google Analytics handles user data, see Google's privacy policy: https://support.google.com/analytics/answer/6004245?hl=en.